Not the Same - comparing COVID jabs with other vaccines
By Craig Paardekooper

ABSTRACT
It is interesting to ask if the reported symptoms of adverse reactions to COVID-19 vaccine differ in any distinct way from those symptoms associated with other vaccines.
In this study I compare the symptoms of COVID-19 vaccines with those of –•••••••FLU vaccine
MUMPS vaccine
TETANUS vaccine
POLIO vaccine
SMALLPOX vaccine
CHOLERA vaccine
YELLOW FEVER vaccine

I also compare the symptoms of COVID-19 vaccines with those of•••••••

IVERMECTIN
HCQ
VITAMIN A
VITAMIN D
VITAMIN C
ASPIRIN
PARACETAMOL

To make this comparison I am using the signal detection method called Proportional Reporting Ratio (PRR). This is the same detection method used by the CDC and by theEMA.

INTRODUCTION
Proportional Reporting Ratio is the method chosen by both the CDC and the EMA to detect safety signals.

USAGE BY CDC
On January 29th of 2021 the CDC released a document titled 'Vaccine Adverse Event Reporting System (VAERS) Standard Operating Procedures for COVID-19' (for officialuse only) which announced the CDC's intention:"CDC will perform Proportional Reporting Ratio (PRR) analysis [...], excluding laboratory results, to identify AEs that are disproportionately reported relative to otherAEs. [...] To determine if results need further clinical review, consider if clinically important, unexpected findings, seriousness, specific syndrome or diagnosis rather
than non-specific symptoms"
Ref : CDC p 11, paragraph 3, 2022-09-26

USAGE BY EMAThe European Medical Association (EMA) uses Proportional Reporting Ratio for signal detection.
“Different statistical methods to generate SDRs are in use. In the EudraVigilance Data Analysis System, the Proportional Reporting Ratio (PRR) has been
implemented in the first release. Other methods will be considered for future implementation.”
Ref : 2006 Report : GUIDELINE ON THE USE OF STATISTICAL SIGNAL DETECTION METHODS IN THE EUDRAVIGILANCE DATA ANALYSIS SYSTEM (europa.eu)

PREVIOUS STUDIES
Proportional Reporting Ratio was used to assess differences between lots of Covid 19 – see https://howbad.info/lethal.html
It was also used to compare the COVID-19 jab with the FLU jab – see https://howbad.info/covid-vs-flu2.pdf
And it was used to detect safety signals for all of the different jabs administered in the USA from 1990 to 2022 – see https://howbad.info/prr7.pdf
Finally, it is the method used by pervaers.com to detect safety signals in the VAERS data – see https://help.pervaers.com
Pervaers.com provides a graphs that help you to identify disproportionate occurrences of a particular symptom with different vaccines – see
https://pervaers.com/?v=COVDATA SOURCE
I used the World Health Organisation’s own database, which is accessible to the public at https://vigiaccess.org
Vigiaccess provided me with a count of the number of reports for each drug, and broke this down by symptom class.

DATA FOR COMPARING COVID-19 VACCINE ADVERSE EFFECTS WITH OTHER VACCINES

Table shows the number of reports of adverse reactions for each organ system and for each vaccine.

The bottom row is the total number of reports for that vaccine
These adverse reaction figures are simply copied directly from Vigiaccess database, exactly as they appear.

DATA COMPARING COVID-19 VACCINE ADVERSE EFFECTS WITH OTHER DRUGS

Table shows the number of reports of adverse reactions for each organ system and for each vaccine.

The bottom row is the total number of reports for that drug
These adverse reaction figures are simply copied directly from Vigiaccess database, exactly as they appear.

METHODPRR calculates the % of reports for drug A that have a particular symptom, and divides this by the % of reports for drug B that have the same symptom. Using PRR, we cansee if drug A consistently stands out with a much higher % of reports for a particular symptom compared to the other drugs.

A PRR score is regarded as a safety signal if •••PRR is greater than 1Lower confidence interval > 1
Number of symptom reports > 3

PRR =( % of reports for drug A with symptom X )-------------------------------------------------------( % of reports for drug B with symptom X )RESULTS

Comparing COVID jab with FLU jab

Comparing COVID jab with MUMPS jab

Comparing COVID jab with TETANUS jab

What is really noticeable is that the COVID jab differs most distinctly from all of these jabs regarding the proportion of reports of Reproductive Disorder, followed byCardiac Disorders.

Comparing COVID jab with POLIO jab

Comparing COVID jab with SMALLPOX jab

Comparing COVID jab with CHOLERA jab

Notice that the same pattern persists - the COVID jab differs most distinctly from all of these jabs regarding the proportion of reports of Reproductive Disorder.

Comparing COVID jab with YELLOW FEVER jab

Comparing COVID jab with IVERMECTIN

Comparing COVID jab with HYDROXYCHLOROQUINE

Notice that the same pattern persists - the COVID jab differs most distinctly from all of these jabs and drugs regarding the proportion of reports of Reproductive Disorder.

Comparing COVID jab with PARACETAMOL

Comparing COVID jab with ASPIRIN

The proportion of reproductive disorders for COVID jabs is 4.5 x the proportion of reproductive disorders for ASPIRIN, but in the case of ASPIRIN this is not the mostprominent difference.

Comparing COVID jab with VITAMIN C

Comparing COVID jab with VITAMIN A

Comparing COVID jab with VITAMIN D

Notice that the same pattern persists - the COVID jab differs most distinctly from all of these jabs and drugs regarding the proportion of reports of Reproductive Disorder.

DISCUSSIONREPRODUCTIVE DISORDERS
The COVID jab, unlike any other vaccine, and unlike all of the drugs and supplements analyzed, appears to target the reproductive system. In EVERY case the proportion ofreports with reproductive disorder after COVID jabs greatly exceeds the proportion of reports with reproductive disorder after any other vaccine. In almost all cases, it is also
true that the proportion of reproductive disorders stands out as the largest difference between COVID and other vaccines.
If COVID jabs cause reproductive disorders, then we might expect the jabs to result in increases in infant mortality. Excess mortality and sudden death have been observedin adults following the COVID jab, so excess mortality would also be expected to occur in the babies of vaccinated mothers. This should be observable as a fall in birth rate inheavily vaccinated countries.

CARDIAC DISORDERS
I found that Cardiac disorder also has a high PRR rank. The sole exception to this was the SMALLPOX vaccine which had TWICE the proportion of cardiac disorders comparedto the COVID jab (the PRR ratio was only 0.5, see “Comparing COVID jab with SMALLPOX jab” above). I thought this was an interesting anomaly, so did a search to see if
SMALLPOX vaccine was associated with cardiac disorder.
This was confirmed in the paper below, demonstrating the power of PRR to detect safety signals.

Case Report: Myocarditis secondary to smallpox vaccination - PMC (nih.gov)
The paper referenced above states that – “ >10% of patients receiving the smallpox vaccine develop new-onset dyspnoea, chest pain or palpitations.”
I found that the PRR for cardiac disorder between COVID jabs and SMALLPOX jabs was 0.5, so if the absolute incidence of cardiac disorder after the SMALLPOX jab is > 10 %,then the absolute incidence of cardiac disorder after the COVID jab is about half that = 5% !